Injection of fibrin sealant including an anesthetic in spinal applications
US8394072B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2009 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | Sep 11, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus. The method includes injecting a fibrin sealant into the disc to reduce at least a portion of the at least one defect, wherein the fibrin sealant injected into the disc comprises an anesthetic, fibrinogen and an activating compound, wherein at least a portion of the fibrin forms after injection, with the proviso that a corticosteroid is absent from the fibrin sealant injected into the disc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.